News and features

Read the latest news and features about our world-leading research, discoveries, fundraising and philanthropy. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.

If you’re a journalist and want to find out more, you can contact our media relations team.

Type:

Division:

Cancer type:

Scientists Reveal Structure of HSP90

19/04/06

See full story

Illumina To Conduct Large-Scale Genotyping

11/04/06

See full story

Illumina to Conduct Large-Scale Genotyping for UK-Based Research Groups Studying Molecular Basis of Prostate Cancer

10/04/06

Study designed to understand genetic susceptibility, mechanisms of disease progression, and cancer therapy management; new agreement mirrors one signed in November

See full story

REOLYSIN® Presentation at ASCO

16/03/06

See full story

The Institute Launches its New Website

10/03/06

See full story

REOLYSIN®/Radiation Abstract on AACR Website

03/03/06

See full story

Gloucester Pharma Reports on Clinical Study

01/03/06

See full story

Making Sense of the PSA Test for Prostate Cancer

21/02/06

See full story

Biovex Begins Phase II Clinical Trials

14/02/06

See full story

Mobile Phones Not Linked To increased Risk Of Brain Tumours

20/01/06

See full story

Milestone Reached in Oncology Collaboration

19/12/05

See full story

New Chair for Top Academic Surgeon

16/12/05

See full story

Make a donation today

5 10 25

A monthly gift can help support our research over several years, so it has the maximum possible benefit for people with cancer.

With GiftAid you'll also be able to add 25% at no extra cost to you

Please choose a donation amount.

5 10 25

With your generous support, we can continue making more discoveries, finding more cures, and saving more lives.

With GiftAid you'll also be able to add 25% at no extra cost to you

Please choose a donation amount.

Our research centres & divisions

Through our close partnerships with The Royal Marsden and other key UK institutions, we're leading a wide breadth of cancer research across eight divisions and more than 25 research centres and strategic initiatives.

Centres and strategic collaborations Our divisions